Skip to Content

Chronic heart failure: New treatment with old drugs

The DANHEART study tests two commonly prescribed drugs in heart failure patients.
The study will test the clinical effect of hydralazine-isosorbide dinitrate (H-HeFT) and metformin (Met-HeFT) in a combined design. H-HeFT will be the first large-scale, randomized study of hydralazine-ISDN in a broader population of heart failure patients. The Met-HeFT study will be the largest randomized study to date of metformin in patients with established heart disease and the first study in heart failure patients designed to address clinical outcomes.

Få tillgång till artikeln

Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.

Back to top